Coprococcus protects against high-fat diet-induced nonalcoholic fatty liver disease in mice
Journal of Applied Microbiology · 03.06.2024 · 135 (6)
DOI: 10.1093/jambio/lxae125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, online erschienen am 03.06.2024. Verfasst von Kaikai Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Xi'an Jiaotong University Health Science Center, Xi'an, Shaan Xi 7…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diet, High-Fat, Probiotics. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Resources Open Sharing Platform Project of Shaanxi Province.
Abstract (Originalsprache)
Aims
The incidence of nonalcoholic fatty liver disease (NAFLD) is increasing annually, leading to substantial medical and health burdens. Numerous studies have demonstrated the potential effectiveness of intestinal probiotics as a treatment strategy for NAFLD. Therefore, the objective of this study is to identify a probiotic for the treatment of NAFLD. Methods and results In this study, blood and fecal samples were collected from 41 healthy volunteers and 44 patients diagnosed with NAFLD. Analysis of the 16S rDNA sequencing data and quantitative real-time PCR (RT-qPCR) revealed a significant reduction in the abundance of Coprococcus in NAFLD patients. Subsequent animal experiments demonstrated that Coprococcus was able to effectively reverse liver lipid accumulation, inflammation, and fibrosis induced by a high-fat diet (HFD) in mice.
Conclusions
This study provides the first in vivo evidence that Coprococcus is a beneficial bacterium capable of preventing NAFLD and has the same probiotic effect in mice as Lactobacillus GG (LGG), a positive control. Therefore, Coprococcus has the potential to serve as a probiotic for the prevention and treatment of NAFLD in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Xi'an Jiaotong University Health Science Center, Xi'an, Shaan Xi 710061, China.
- Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Ministry of Education of China, Xi'an, Shaan Xi 710061, China.
- Department of Planned Immunization, Xi'an Center for Disease Control and Prevention, No. 599 Xiying Road, Yanta District, Xi'an 710054 Shaanxi, China.
- Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center of China, Beijing 100034, China.
- Department of Clinical Laboratory, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, Shaanxi 710004, P.R. China.
- Department of Pharmacology, University of Health Sciences, Lahore 54600, Pakistan.
Förderung
- National Natural Science Foundation of China
- Science and Technology Resources Open Sharing Platform Project of Shaanxi Province
Zitieren
APA
Lu, K., Zhou, Y., He, L., Li, Y., Shahzad, M., & Li, D. (2024). Coprococcus protects against high-fat diet-induced nonalcoholic fatty liver disease in mice. Journal of Applied Microbiology, 135(6). https://doi.org/10.1093/jambio/lxae125
Vancouver
Lu K, Zhou Y, He L, Li Y, Shahzad M, Li D. Coprococcus protects against high-fat diet-induced nonalcoholic fatty liver disease in mice. Journal of Applied Microbiology. 2024;135(6). doi:10.1093/jambio/lxae125
BibTeX
@article{Lu2024,
author = {Lu, Kaikai and Zhou, Yimeng and He, Lei and Li, Ya and Shahzad, Muhammad and Li, Dongmin},
title = {Coprococcus protects against high-fat diet-induced nonalcoholic fatty liver disease in mice},
journal = {Journal of Applied Microbiology},
year = {2024},
volume = {135},
number = {6},
doi = {10.1093/jambio/lxae125}
}
EUVIMED